ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

QOL Of Young Survivors Equal To Other Children

February 25, 2005

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

DCE Advisers Okay Cooperative Agreements For Epidemiolgic Of Esophageal Cancers

March 29, 1991